The power to know

Prolaio is rolling out its services in 2024 in the US. Heart failure patients can obtain the system through our network of partner hospitals. Ask your doctor if Prolaio is available where you get your care. If not available at your healthcare institution, your provider can make a request through the signup link on the Prolaio website. Hypertrophic cardiomyopathy patients can access the system directly, wherever they are, beginning in July. Complete the registration link on the Prolaio website, and the Prolaio team can set you up once they confirm eligibility.

Prolaio is a complete system. You'll use wearable devices like a smart watch or ECG patch, at-home devices like a blood pressure cuff and a scale, and you’ll be guided to complete periodic questionnaires. Information about your monitoring progress will be continuously available through the Prolaio app. Prolaio’s Clinical Management Center, staffed by licensed medical professionals, will review patient information and provide summaries, with insights in some cases. Reports about your medical condition will be conveyed in reports to your prescribing providers, preparing them to give you feedback on your progress. For patients enrolling directly through the Prolaio website, reports will be reviewed by the experts in the Prolaio Clinical Management Center, and you’ll receive a copy.

Prolaio is building on precedents for remote patient monitoring and telemedicine. We are engaging hospitals, health systems, and payers to work out business terms, which may take some time. For early users, the system will be provided at no charge. We want to keep out-of-pocket costs to a minimum.

The Prolaio system is initially available to US-based patients with heart failure or hypertrophic cardiomyopathy. The system is part of your medical care, and requires a prescription from your care team or from the Prolaio Clinical Management Center team.

For heart failure patients: Prolaio is being introduced for patients finishing a stay in the hospital for heart failure. If your hospital uses the Prolaio system, your care team will qualify you for Prolaio monitoring and set you up before you leave the hospital.

For hypertrophic cardiomyopathy patients: Prolaio is available to patients with a diagnosis of hypertrophic cardiomyopathy who have experienced symptoms in the last six months. Prolaio’s Clinical Management Center experts will review your case to confirm eligibility, and then will generate the necessary prescriptions to get you started.

Prolaio is focused on conditions with significant care gaps and where outcomes and patient quality of life have the most potential for improvement. Our initial rollouts are:

• Heart failure transition care: when a patient is discharged after a heart failure hospitalization. Our goal is to prevent hospital readmissions, which represent a strain on patients, providers, health institutions, and the healthcare system overall.
• Hypertrophic cardiomyopathy: targeting patients who have had symptoms within the last six months. Our goal is to provide patients greater transparency into their disease progression, so they can live with greater confidence and obtain care in accordance with their symptoms.

Prolaio monitoring generates continuous data, analyzed and returned in periodic reports that are electronic and printable. For heart failure, these reports are given to a patient’s prescribing care team. For hypertrophic cardiomyopathy, reports are returned directly to the patient as well as to the prescribing care team, and may be shared by the patient with their personal care provider.

In pilot programs, Prolaio has experienced nearly 100% patient adherence to its monitoring regimen. Patients report high satisfaction in having a meaningful participation role in the management of their own care.

The Prolaio system is designed to make care teams more efficient and effective. The only incremental effort is setting up a patient before they leave the hospital. Troubleshooting of devices will be handled by Prolaio, so that won’t be extra work for you or your staff. As you use the system, you may find that Prolaio monitoring helps you identify the patients you need to see for office visits. That means you’d see patients driven by data rather than by routine visits, and may confer fewer urgent visits to the emergency room. We’ll be collecting data on our system’s impact on hospital utilization, but we are optimistic that managing patients in this manner can reduce strain on emergency rooms and hospital resources.

Prolaio keeps your information private. You will provide a health data authorization up front, and you can revoke it if you want to. Your data will be provided in reports to your designated providers only.

We take reasonable and appropriate steps to help protect personal information from unauthorized access, use, disclosure, alteration, and destruction. To help us protect personal information, we request that you use a strong password and never share your password with anyone or use the same password with other sites or accounts.

Participants in the Prolaio system will agree to make their de-identified data available to Prolaio for the continuous improvement of its own monitoring algorithms and to biomedical researchers for the development of new treatments. De-identified information cannot be traced back to you.